• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒的内源性唾液抑制剂

Endogenous salivary inhibitors of human immunodeficiency virus.

作者信息

Shugars D C, Alexander A L, Fu K, Freel S A

机构信息

Department of Dental Ecology, School of Dentistry, University of North Carolina at Chapel Hill, USA.

出版信息

Arch Oral Biol. 1999 Jun;44(6):445-53. doi: 10.1016/s0003-9969(99)00003-5.

DOI:10.1016/s0003-9969(99)00003-5
PMID:10401522
Abstract

The human immunodeficiency virus type 1 (HIV-1) is rarely transmitted through salivary secretions, due in part to the presence of endogenous inhibitors. Here, the protective characteristics of the intraoral environment are summarized and inhibitory factors that reduce HIV-1 infectivity in vitro described, focusing on secretory leucocyte protease inhibitor (SLPI), a 12-kDa mucosal protein that blocks HIV infection in several cell-culture systems. SLPI appears to interact with a cellular surface molecule to limit viral entry into target cells. To determine whether the inhibitor has a similar role in vivo, the contribution of salivary SLPI to anti-HIV-1 activity was assessed. Whole unstimulated filtered salivas from infected and uninfected donors contained similar concentrations of the inhibitor. Depletion from SLPI filtered saliva produced a corresponding loss of inhibitory activity. In general, filtered whole salivas obtained from 10 donors had antiviral activities that correlated positively with SLPI concentrations. However, some samples having SLPI well below the concentration required for inhibitory activity in vitro exhibited modest inhibition, suggesting the presence of other anti-HIV-1 components in oral fluids. Thus, SLPI is a major but not sole inhibitor of this virus in saliva.

摘要

1型人类免疫缺陷病毒(HIV-1)很少通过唾液分泌物传播,部分原因是存在内源性抑制剂。在此,总结口腔内环境的保护特性,并描述在体外降低HIV-1感染性的抑制因子,重点是分泌型白细胞蛋白酶抑制剂(SLPI),一种12 kDa的黏膜蛋白,它在多种细胞培养系统中可阻断HIV感染。SLPI似乎与一种细胞表面分子相互作用,以限制病毒进入靶细胞。为了确定该抑制剂在体内是否具有类似作用,评估了唾液SLPI对抗HIV-1活性的贡献。来自感染和未感染供体的未刺激过滤全唾液中含有相似浓度的该抑制剂。从过滤唾液中去除SLPI会导致相应的抑制活性丧失。一般来说,从10名供体获得的过滤全唾液具有与SLPI浓度呈正相关的抗病毒活性。然而,一些SLPI浓度远低于体外抑制活性所需浓度的样本表现出适度的抑制作用,这表明口腔液中存在其他抗HIV-1成分。因此,SLPI是唾液中该病毒的主要但非唯一抑制剂。

相似文献

1
Endogenous salivary inhibitors of human immunodeficiency virus.人类免疫缺陷病毒的内源性唾液抑制剂
Arch Oral Biol. 1999 Jun;44(6):445-53. doi: 10.1016/s0003-9969(99)00003-5.
2
Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.人唾液中分泌型白细胞蛋白酶抑制剂(SLPI)的抑制功能具有HIV-1特异性,并随病毒嗜性而变化。
Oral Dis. 2002 May;8(3):160-7. doi: 10.1034/j.1601-0825.2002.01807.x.
3
Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.黏膜组织中HIV-1与其内源性抑制剂之间的解剖学分离。
Am J Pathol. 1997 Apr;150(4):1275-84.
4
Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.粘膜液中的分泌型白细胞蛋白酶抑制剂(SLPI)可抑制HIV-1。
Oral Dis. 1997 May;3 Suppl 1:S64-9. doi: 10.1111/j.1601-0825.1997.tb00377.x.
5
Endogenous mucosal antiviral factors of the oral cavity.口腔内源性黏膜抗病毒因子。
J Infect Dis. 1999 May;179 Suppl 3:S431-5. doi: 10.1086/314799.
6
Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.分泌型白细胞蛋白酶抑制剂可阻断人免疫缺陷病毒I型嗜单核细胞和嗜淋巴细胞毒株对原代单核细胞和单核细胞的感染性。
Oral Dis. 1997 May;3 Suppl 1:S70-2. doi: 10.1111/j.1601-0825.1997.tb00379.x.
7
The role of the oral environment in HIV-1 transmission.口腔环境在HIV-1传播中的作用。
J Am Dent Assoc. 1998 Jul;129(7):851-8. doi: 10.14219/jada.archive.1998.0349.
8
Salivary secretory leukocyte protease inhibitor increases in HIV infection.唾液分泌型白细胞蛋白酶抑制剂在HIV感染中会增加。
J Oral Pathol Med. 2004 Aug;33(7):410-6. doi: 10.1111/j.1600-0714.2004.00218.x.
9
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.分泌型白细胞蛋白酶抑制剂:一种在体外具有抗人免疫缺陷病毒1活性的人唾液蛋白。
J Clin Invest. 1995 Jul;96(1):456-64. doi: 10.1172/JCI118056.
10
Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.分泌型白细胞蛋白酶抑制剂对1型人类免疫缺陷病毒感染性的抑制作用发生在病毒逆转录之前。
Blood. 1997 Aug 1;90(3):1141-9.

引用本文的文献

1
Determinants of Tenascin-C and HIV-1 envelope binding and neutralization.Tenascin-C 和 HIV-1 包膜结合和中和的决定因素。
Mucosal Immunol. 2019 Jul;12(4):1004-1012. doi: 10.1038/s41385-019-0164-2. Epub 2019 Apr 11.
2
Factors contributing to salivary human immunodeficiency virus type-1 levels measured by a Poisson distribution-based PCR method.通过基于泊松分布的聚合酶链反应方法检测唾液中人类免疫缺陷病毒1型水平的影响因素。
J Int Med Res. 2018 Mar;46(3):996-1007. doi: 10.1177/0300060517728652. Epub 2017 Nov 9.
3
Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
黏液和黏蛋白:它们在抑制人类免疫缺陷病毒中发挥作用吗?
Virol J. 2017 Oct 6;14(1):192. doi: 10.1186/s12985-017-0855-9.
4
Saliva and viral infections.唾液与病毒感染。
Periodontol 2000. 2016 Feb;70(1):93-110. doi: 10.1111/prd.12112.
5
Heat-stable molecule derived from Streptococcus cristatus induces APOBEC3 expression and inhibits HIV-1 replication.源自牙龈链球菌的热稳定分子诱导载脂蛋白B编辑酶催化多肽样蛋白3表达并抑制HIV-1复制。
PLoS One. 2014 Aug 28;9(8):e106078. doi: 10.1371/journal.pone.0106078. eCollection 2014.
6
A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.直肠和口腔黏膜可溶性免疫因子环境的比较蛋白质组学分析
PLoS One. 2014 Jun 30;9(6):e100820. doi: 10.1371/journal.pone.0100820. eCollection 2014.
7
HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors.口腔中的 HIV 脱落:对 HIV 类型、免疫病毒学、人口统计学和口腔因素的评估。
Sex Transm Infect. 2012 Feb;88(1):45-50. doi: 10.1136/sextrans-2011-050231.
8
Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque saliva.口腔中猴免疫缺陷病毒(SIV)的特征及恒河猴唾液对SIV的体外抑制作用
AIDS Res Hum Retroviruses. 2010 Aug;26(8):901-11. doi: 10.1089/aid.2009.0235.
9
Oral infectious diseases: a potential risk factor for HIV virus recrudescence?口腔感染性疾病:HIV病毒复发的潜在危险因素?
Oral Dis. 2009 Jul;15(5):313-27. doi: 10.1111/j.1601-0825.2009.01533.x. Epub 2009 Apr 2.
10
The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay.在抑制试验中,粗制和纯化的人妊娠栓黏液及黏蛋白对1型人类免疫缺陷病毒活性的抑制作用。
Virol J. 2008 May 19;5:59. doi: 10.1186/1743-422X-5-59.